Recent discussions on X about Houlihan Lokey (HLI) have centered around the stock's impressive performance and technical indicators. Posts highlight a notable breakout in the stock's price pattern, with some pointing to supportive volume trends and a strong base formation as signs of potential upward momentum. This buzz comes alongside news of the company reaching a new 52-week high, fueling further interest among market watchers.
Additionally, there’s chatter about institutional investments, with several large funds reportedly increasing their stakes in HLI, as noted in recent financial filings shared on the platform. The stock's long-term performance, including significant returns over the past decade, has also been a topic of conversation, with some users marveling at its consistent outperformance compared to broader market indices. These discussions reflect a keen focus on both technical and fundamental aspects of the company’s trajectory.
Note: This discussion summary was generated from an AI condensation of post data.
Houlihan Lokey Congressional Stock Trading
Members of Congress have traded $HLI stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HLI stock by members of Congress over the last 6 months:
- REPRESENTATIVE KELLY MORRISON sold up to $15,000 on 06/04.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 04/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Houlihan Lokey Insider Trading Activity
Houlihan Lokey insiders have traded $HLI stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $HLI stock by insiders over the last 6 months:
- PAUL ERIC SIEGERT (CO-CHAIRMAN) sold 40,000 shares for an estimated $7,998,000
- SCOTT L BEISER (CO-CHAIRMAN) sold 8,008 shares for an estimated $1,431,109
- IRWIN GOLD (CO-CHAIRMAN) sold 5,000 shares for an estimated $914,050
- GILLIAN BETH ZUCKER has made 0 purchases and 5 sales selling 1,000 shares for an estimated $171,432.
- CHRISTOPHER M CRAIN (GENERAL COUNSEL) sold 500 shares for an estimated $86,510
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Houlihan Lokey Hedge Fund Activity
We have seen 261 institutional investors add shares of Houlihan Lokey stock to their portfolio, and 300 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 681,657 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $122,664,177
- CHAMPLAIN INVESTMENT PARTNERS, LLC added 361,085 shares (+194.9%) to their portfolio in Q2 2025, for an estimated $64,977,245
- THRIVENT FINANCIAL FOR LUTHERANS removed 353,812 shares (-98.4%) from their portfolio in Q2 2025, for an estimated $63,668,469
- CAPITAL RESEARCH GLOBAL INVESTORS added 294,781 shares (+58.5%) to their portfolio in Q2 2025, for an estimated $53,045,840
- PRUDENTIAL FINANCIAL INC removed 266,988 shares (-76.8%) from their portfolio in Q1 2025, for an estimated $43,118,562
- RENAISSANCE GROUP LLC added 189,583 shares (+inf%) to their portfolio in Q2 2025, for an estimated $34,115,460
- ASSENAGON ASSET MANAGEMENT S.A. added 182,729 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,882,083
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Houlihan Lokey Government Contracts
We have seen $24,903 of award payments to $HLI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Houlihan Lokey Analyst Ratings
Wall Street analysts have issued reports on $HLI in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/14/2025
- Wells Fargo issued a "Overweight" rating on 07/11/2025
- Morgan Stanley issued a "Overweight" rating on 06/23/2025
To track analyst ratings and price targets for Houlihan Lokey, check out Quiver Quantitative's $HLI forecast page.
Houlihan Lokey Price Targets
Multiple analysts have issued price targets for $HLI recently. We have seen 4 analysts offer price targets for $HLI in the last 6 months, with a median target of $200.5.
Here are some recent targets:
- Alex Bond from Keefe, Bruyette & Woods set a target price of $232.0 on 07/14/2025
- Michael Brown from Wells Fargo set a target price of $209.0 on 07/11/2025
- Ryan Kenny from Morgan Stanley set a target price of $192.0 on 06/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
